COSA 2020: Netupitant + Palonosetron May Offer Advantages in Patients Undergoing Melphalan Conditioning for aSCT
Certain parameters of delayed CINV improved.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.